new ceo and board 'business model', page-26

wasn't sally doing oxy

Sally Kinrade's Overview- did I miss her leaving or am I msitaken as she was in on Esra watch?

12 july

The Tretinoin/TPM® clinical program is being overseen by our recently appointed Chief
Operating Officer (COO), Sally Kinrade, who is responsible for managing clinical
programs and all operational activities of the Company. Ms Kinrade has worked for
Glaxo Smith Kline (Aust) for 20 years with the last 15 in Senior Management positions.
She is a Registered Pharmacist and has been involved in the development of drugs from
concept through to market launch and consolidation. She has in depth knowledge of
clinical operations, both in project delivery and process quality improvement

Who is our current coo?.

Current

Board Director at ARCS Australia Ltd
Principal at Innervate Consulting

Past

Chief Operating Officer at Phosphagenics Ltd.
Head of Medical Collaborations (Oncology) at GlaxoSmithKline Australia
Medical Manager, Oncology at GlaxoSmithKline

see all